These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 4045996

  • 1. Natural killing (NK) potential of cord blood lymphocytes.
    Toder V, Durdana A, Elrad H, Gleicher N.
    J Clin Lab Immunol; 1985 May; 17(1):29-32. PubMed ID: 4045996
    [Abstract] [Full Text] [Related]

  • 2. Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood.
    Seki H, Ueno Y, Taga K, Matsuda A, Miyawaki T, Taniguchi N.
    J Immunol; 1985 Oct; 135(4):2351-6. PubMed ID: 3928745
    [Abstract] [Full Text] [Related]

  • 3. Lymphocyte subpopulations in the neonate: high percentage of circulating B73.1+, HNK-1- cells.
    Montagna D, Ferremi P, Alberini C, Porta FA, de Amici M, Astaldi-Ricotti GC, Maccario R, Ugazio AG.
    Thymus; 1986 Oct; 8(3):171-6. PubMed ID: 3750384
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of diminished natural killer cell activity in pregnant women and neonates.
    Baley JE, Schacter BZ.
    J Immunol; 1985 May; 134(5):3042-8. PubMed ID: 3980989
    [Abstract] [Full Text] [Related]

  • 5. Natural cytotoxicity in the neonate: high levels of lymphokine activated killer (LAK) activity.
    Montagna D, Maccario R, Ugazio AG, Mingrat G, Burgio GR.
    Clin Exp Immunol; 1988 Jan; 71(1):177-81. PubMed ID: 2964956
    [Abstract] [Full Text] [Related]

  • 6. Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients.
    Balch CM, Tilden AB, Dougherty PA, Cloud GA, Abo T.
    Surgery; 1984 Jan; 95(1):63-70. PubMed ID: 6581546
    [Abstract] [Full Text] [Related]

  • 7. Characterization of HNK-1+ (Leu-7) human lymphocytes. II. Distinguishing phenotypic and functional properties of natural killer cells from activated NK-like cells.
    Abo T, Balch CM.
    J Immunol; 1982 Oct; 129(4):1758-61. PubMed ID: 7108226
    [Abstract] [Full Text] [Related]

  • 8. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B, Lebow LT, Bradley TP.
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [Abstract] [Full Text] [Related]

  • 9. Natural killer cell function of human neonatal lymphocytes.
    Uksila J, Lassila O, Hirvonen T.
    Clin Exp Immunol; 1982 Jun; 48(3):649-54. PubMed ID: 6180853
    [Abstract] [Full Text] [Related]

  • 10. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
    Burns GF, Triglia T, Werkmeister JA.
    J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
    [Abstract] [Full Text] [Related]

  • 11. Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single-cell cytotoxicity assays.
    Gregory CD, Lee H, Rees GB, Scott IV, Shah LP, Golding PR.
    Clin Exp Immunol; 1985 Oct; 62(1):121-7. PubMed ID: 3864569
    [Abstract] [Full Text] [Related]

  • 12. Surface markers and cytotoxic activity of blood natural killer cells studied at the single cell level in Hodgkin's disease.
    Jezewska E, Björkholm M, Giscombe R, Holm G, Tullgren O.
    Clin Exp Immunol; 1985 Jul; 61(1):96-102. PubMed ID: 4042422
    [Abstract] [Full Text] [Related]

  • 13. The relationship of HNK-1 (Leu 7) and VEP13 antigens on human cells mediating natural killing.
    Rumpold H, Kraft D, Gastl G, Huber C.
    Clin Exp Immunol; 1984 Sep; 57(3):703-9. PubMed ID: 6467685
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability.
    Abo T, Cooper MD, Balch CM.
    J Immunol; 1982 Oct; 129(4):1752-7. PubMed ID: 6980948
    [Abstract] [Full Text] [Related]

  • 17. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
    Condiotti R, Nagler A.
    Exp Hematol; 1998 Jul; 26(7):571-9. PubMed ID: 9657131
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G, Spuzić I.
    Srp Arh Celok Lek; 1995 Jul; 123(9-10):227-31. PubMed ID: 17974436
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.